---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-159094"
form_type: "8-K"
ticker: "CTKB"
cik: "0001831915"
company_name: "Cytek Biosciences, Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:07:10.069445+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cytek Biosciences 2024 annual meeting results: all proposals approved by shareholders

## Summary
- Elected Wenbin Jiang and Michael Holder as Class III directors with 64.2M and 70.3M votes for, respectively.
- Advisory vote on executive compensation approved: 63.5M for, 10.5M against, 78.9K abstentions.
- Ratified Deloitte & Touche LLP as independent auditor for FY2024: 94.1M for, 2.3M against, 656.7K abstentions.
- Approximately 74% of outstanding shares (97.1M of 131.3M) represented at the meeting.

## SEC filing metadata
- accession: 0001193125-24-159094
- form_type: 8-K
- ticker: CTKB
- cik: 0001831915
- company_name: Cytek Biosciences, Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/0001193125-24-159094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/d841203d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-159094
- JSON: https://secwatch.observer/filing/0001193125-24-159094.json
- Plain text: https://secwatch.observer/filing/0001193125-24-159094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.